The lack of oxygen-carrying red blood cells can also affect the functioning of various organs in the body
BPC-157 vs TB-500: the 2026 research peptide comparison for tissue regeneration and repair BPC-157 vs TB-500: two research stars in tissue repair Two peptides have dominated research on musculotendinous regeneration, intestinal healing and vascular repair for a decade: BPC-157 (Body Protection Compound 15 amino acids, derived from a human gastric protein) and TB-500 (active 17-mer fragment of endogenous Thymosin -4)
To name just a few: fatigue, breathlessness, dizziness, diarrhoea, dementia, depression, tachycardia, swollen and sore joints, blurred vision, pain and numbness (or burning) in hands and feet, sore muscles, sore tongue, inability to walk (later)
For the full BPC-157 dosing breakdown, see our BPC-157 dosage protocol guide: BPC-157: 200 to 500 mcg per day, subcutaneous injection near the injury site, 4 to 8 weeks TB-500 loading phase (Weeks 1-4): 2 to 5 mg twice per week TB-500 maintenance phase (Weeks 5-8): 2 mg once per week Route: Both peptides are administered via subcutaneous injection
Betametasona 0,3 mg